Literature DB >> 10617785

Characterization and purification of porcine small intestinal mucus receptor for Escherichia coli K88ac fimbrial adhesin.

L Z Jin1, R R Marquardt, S K Baidoo, A A Frohlich.   

Abstract

The objectives of this study were to investigate the nature of, and to purify K88ac fimbrial adhesin-specific receptors in the mucus from the small intestine of piglet. Adhesion was studied by incubating (3)H-labeled Escherichia coli with mucus that were treated with or without pronase, proteinase, trypsin or sodium metaperiodate. The results indicated that treatment with either proteolytic enzymes or sodium metaperiodate (to oxidize sugars) significantly reduced E. coli K88ac or K88+MB adhesion to the mucus, suggesting that the K88ac and K88+MB specific receptors in this preparation were, at least in part, glycoprotein in nature. The K88+MB fimbriae specific receptor was purified using affinity chromatography. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of the purified K88+MB specific receptor together with the above data suggested that the receptor from the mucus of the small intestine of the pig was a 80-kDa glycoprotein.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10617785     DOI: 10.1111/j.1574-695X.2000.tb01406.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  3 in total

1.  A strain of Enterococcus faecium (18C23) inhibits adhesion of enterotoxigenic Escherichia coli K88 to porcine small intestine mucus.

Authors:  L Z Jin; R R Marquardt; X Zhao
Journal:  Appl Environ Microbiol       Date:  2000-10       Impact factor: 4.792

2.  Homology modeling, comparative genomics and functional annotation of Mycoplasma genitalium hypothetical protein MG_237.

Authors:  Azeem Mehmood Butt; Maria Batool; Yigang Tong
Journal:  Bioinformation       Date:  2011-11-20

Review 3.  Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems.

Authors:  Deepak A Subramanian; Robert Langer; Giovanni Traverso
Journal:  J Nanobiotechnology       Date:  2022-08-06       Impact factor: 9.429

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.